Interleukin-6 and B-type natriuretic peptide are independent predictors for worsening of heart failure in patients with progressive congestive heart failure

被引:47
作者
Gwechenberger, M [1 ]
Hülsmann, M [1 ]
Berger, R [1 ]
Graf, S [1 ]
Springer, C [1 ]
Stanek, B [1 ]
Pacher, R [1 ]
机构
[1] Univ Vienna, Dept Cardiol, A-1090 Vienna, Austria
关键词
D O I
10.1016/j.healun.2003.07.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Neurohormones and cytokines have been associated with poor prognosis in patients with congestive heart failure. However, direct comparisons between them are rare and the best predictor for worsening of heart failure remains to be elucidated. The aim of the study was to identify independent predictors for worsening of heart failure. Methods: We studied 100 patients with congestive heart failure (LVEF less than or equal to25%). Serum levels of interleukin-6 (IL-6), tumor necrosis factor (TNF)-alpha, aminoterminal atrial natriuretic peptide (N-ANP), B-type natriuretic peptide (BNP), aminoterminal B-type natriuretic peptide (N-BNP), norepinephrine (NE) and big endothelin (big ET) were measured at entry into the study. Univariate and stepwise multivariate regression analyses were performed to compare variables and clinical parameters. The end-point was defined as worsening of heart failure. Results: During follow-up (mean 378 days), 30 patients reached the defined end-point. Univariate risk factors of worsening of heart failure were IL-6 (p = 0.0001), log BNP (p = 0.0001), log N-ANP (p = 0.0259), big ET (p = 0.0032), log N-BNP (p = 0.0495), NE (p = 0.0013) and LVEF (p = 0.0498). Multivariate regression analysis identified IL-6 as the strongest independent predictive value for worsening of heart failure (p = 0.0001), followed by log BNP (p = 0.0002). Mean IL-6 levels were 1.76 +/- 1.73 in stable patients and 4.62 +/- 7.98 pg/ml in patients who developed worsening of heart failure. Using a cut-off value of 1.66 pg/ml for IL-6 Kaplan-Meier freedom from worsening, heart failure was significantly higher in patients below this cut-off point compared with those above (P = 0.0002). Conclusions: IL-6 and BNP independently predict worsening of heart failure. A single measurement could help to identify patients at high risk for worsening of heart failure and these individuals should be monitored more closely.
引用
收藏
页码:839 / 844
页数:6
相关论文
共 28 条
[1]   B-type natriuretic peptide predicts sudden death in patients with chronic heart failure [J].
Berger, R ;
Huelsman, M ;
Strecker, K ;
Bojic, A ;
Moser, P ;
Stanek, B ;
Pacher, R .
CIRCULATION, 2002, 105 (20) :2392-2397
[2]  
Deswal A, 2001, CIRCULATION, V103, P2055
[3]   INTERLEUKIN-6 (IL-6) AS A MEDIATOR OF STUNNED MYOCARDIUM [J].
FINKEL, MS ;
HOFFMAN, RA ;
SHEN, L ;
ODDIS, CV ;
SIMMONS, RL ;
HATTLER, BG .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (13) :1231-1232
[4]   NEGATIVE INOTROPIC EFFECTS OF CYTOKINES ON THE HEART MEDIATED BY NITRIC-OXIDE [J].
FINKEL, MS ;
ODDIS, CV ;
JACOB, TD ;
WATKINS, SC ;
HATTLER, BG ;
SIMMONS, RL .
SCIENCE, 1992, 257 (5068) :387-389
[5]   CYTOKINE SIGNALING DURING MYOCARDIAL-INFARCTION - SEQUENTIAL APPEARANCE OF IL-1-BETA AND IL-6 [J].
GUILLEN, I ;
BLANES, M ;
GOMEZLECHON, MJ ;
CASTELL, JV .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1995, 269 (02) :R229-R235
[6]   Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions [J].
Gwechenberger, M ;
Mendoza, LH ;
Youker, KA ;
Frangogiannis, NG ;
Smith, CW ;
Michael, LH ;
Entman, ML .
CIRCULATION, 1999, 99 (04) :546-551
[7]   CONTINUOUS ACTIVATION OF GP130, A SIGNAL-TRANSDUCING RECEPTOR COMPONENT FOR INTERLEUKIN 6-RELATED CYTOKINES, CAUSES MYOCARDIAL HYPERTROPHY IN MICE [J].
HIROTA, H ;
YOSHIDA, K ;
KISHIMOTO, T ;
TAGA, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) :4862-4866
[8]   Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living with Heart Failure Questionnaire in an outpatient cohort with congestive heart failure [J].
Hülsmann, M ;
Berger, R ;
Sturm, B ;
Bojic, A ;
Woloszczuk, W ;
Bergler-Klein, J ;
Pacher, R .
EUROPEAN HEART JOURNAL, 2002, 23 (11) :886-891
[9]   Do cytokines enable risk stratification to be improved in NYHA functional class III patients?: Comparison with other potential predictors of prognosis [J].
Kell, R ;
Haunstetter, A ;
Dengler, TJ ;
Zugck, C ;
Kübler, W ;
Haass, M .
EUROPEAN HEART JOURNAL, 2002, 23 (01) :70-78
[10]  
Koller-Strametz J, 1998, J HEART LUNG TRANSPL, V17, P356